Skip to content

Breaking News

Dr. Richard Pratley (right) does work for a diabetes study at AdventHealth’s Translational Research Institute in Orlando, Fla. (Courtesy of AdventHealth)
Dr. Richard Pratley (right) does work for a diabetes study at AdventHealth’s Translational Research Institute in Orlando, Fla. (Courtesy of AdventHealth)
Author
PUBLISHED: | UPDATED:

As chronic kidney disease rises nationwide, a new study partially conducted in Orlando suggests weight loss drugs like Ozempic and Wegovy could be part of the solution.

Subscribe to continue reading this article.

Already subscribed? To login in, click here.